vs

Side-by-side financial comparison of CapsoVision, Inc (CV) and PRECISION OPTICS CORPORATION, INC. (POCI). Click either name above to swap in a different company.

PRECISION OPTICS CORPORATION, INC. is the larger business by last-quarter revenue ($7.4M vs $3.5M, roughly 2.1× CapsoVision, Inc). PRECISION OPTICS CORPORATION, INC. runs the higher net margin — -24.2% vs -223.9%, a 199.7% gap on every dollar of revenue.

CapsoVision, Inc. is a medical technology firm specializing in the development and manufacturing of advanced capsule endoscopy systems and supporting diagnostic solutions. Its non-invasive gastrointestinal imaging products are supplied to hospitals, gastroenterology clinics and medical specialists across global markets, supporting more accurate detection of digestive diseases and improved patient care experiences.

Century Precision Optics is an American lens manufacturing firm. It was founded in 1948 in North Hollywood, California as Century Photo Optics. Steven Manios Sr. purchased the company in 1973 and created many of the optics. Century Optics makes a variety of digital, broadcast, projection, and industrial lenses. They have offices in Hauppauge, New York and Van Nuys, California.

CV vs POCI — Head-to-Head

Bigger by revenue
POCI
POCI
2.1× larger
POCI
$7.4M
$3.5M
CV
Higher net margin
POCI
POCI
199.7% more per $
POCI
-24.2%
-223.9%
CV

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
CV
CV
POCI
POCI
Revenue
$3.5M
$7.4M
Net Profit
$-7.9M
$-1.8M
Gross Margin
54.1%
2.8%
Operating Margin
-226.7%
-23.6%
Net Margin
-223.9%
-24.2%
Revenue YoY
62.8%
Net Profit YoY
-83.6%
EPS (diluted)
$-0.17
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CV
CV
POCI
POCI
Q4 25
$7.4M
Q3 25
$3.5M
$6.7M
Q2 25
$3.3M
$6.2M
Q1 25
$4.2M
Q4 24
$4.5M
Q3 24
$4.2M
Q2 24
$4.7M
Q1 24
$5.2M
Net Profit
CV
CV
POCI
POCI
Q4 25
$-1.8M
Q3 25
$-7.9M
$-1.6M
Q2 25
$-4.6M
$-1.4M
Q1 25
$-2.1M
Q4 24
$-969.7K
Q3 24
$-1.3M
Q2 24
$-1.4M
Q1 24
$-317.1K
Gross Margin
CV
CV
POCI
POCI
Q4 25
2.8%
Q3 25
54.1%
14.2%
Q2 25
54.6%
12.9%
Q1 25
10.0%
Q4 24
23.6%
Q3 24
26.6%
Q2 24
21.7%
Q1 24
35.5%
Operating Margin
CV
CV
POCI
POCI
Q4 25
-23.6%
Q3 25
-226.7%
-23.9%
Q2 25
-140.3%
-21.9%
Q1 25
-48.7%
Q4 24
-20.1%
Q3 24
-29.7%
Q2 24
-28.8%
Q1 24
-4.9%
Net Margin
CV
CV
POCI
POCI
Q4 25
-24.2%
Q3 25
-223.9%
-24.5%
Q2 25
-139.5%
-22.7%
Q1 25
-50.1%
Q4 24
-21.4%
Q3 24
-31.2%
Q2 24
-29.9%
Q1 24
-6.0%
EPS (diluted)
CV
CV
POCI
POCI
Q4 25
$-0.23
Q3 25
$-0.17
$-0.21
Q2 25
$-2.02
$-0.19
Q1 25
$-0.30
Q4 24
$-0.15
Q3 24
$-0.21
Q2 24
$-0.23
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CV
CV
POCI
POCI
Cash + ST InvestmentsLiquidity on hand
$881.5K
Total DebtLower is stronger
$1.6M
Stockholders' EquityBook value
$20.4M
$9.3M
Total Assets
$25.7M
$22.9M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CV
CV
POCI
POCI
Q4 25
$881.5K
Q3 25
$1.4M
Q2 25
$1.8M
Q1 25
$2.5M
Q4 24
$212.4K
Q3 24
$635.6K
Q2 24
$405.3K
Q1 24
$925.1K
Total Debt
CV
CV
POCI
POCI
Q4 25
$1.6M
Q3 25
$1.8M
Q2 25
$1.9M
Q1 25
$2.1M
Q4 24
$2.1M
Q3 24
$2.1M
Q2 24
$2.2M
Q1 24
$2.3M
Stockholders' Equity
CV
CV
POCI
POCI
Q4 25
$9.3M
Q3 25
$20.4M
$10.9M
Q2 25
$-139.0M
$12.3M
Q1 25
$13.2M
Q4 24
$9.5M
Q3 24
$10.1M
Q2 24
$10.1M
Q1 24
$11.3M
Total Assets
CV
CV
POCI
POCI
Q4 25
$22.9M
Q3 25
$25.7M
$22.4M
Q2 25
$9.5M
$19.8M
Q1 25
$19.6M
Q4 24
$17.5M
Q3 24
$17.2M
Q2 24
$16.9M
Q1 24
$18.3M
Debt / Equity
CV
CV
POCI
POCI
Q4 25
0.17×
Q3 25
0.16×
Q2 25
0.16×
Q1 25
0.16×
Q4 24
0.22×
Q3 24
0.21×
Q2 24
0.22×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CV
CV
POCI
POCI
Operating Cash FlowLast quarter
$-5.7M
$-256.1K
Free Cash FlowOCF − Capex
$-5.7M
FCF MarginFCF / Revenue
-160.5%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CV
CV
POCI
POCI
Q4 25
$-256.1K
Q3 25
$-5.7M
$78.2K
Q2 25
$-9.5M
$-569.2K
Q1 25
$-1.9M
Q4 24
$-786.8K
Q3 24
$-318.6K
Q2 24
$-976.0K
Q1 24
$-214.2K
Free Cash Flow
CV
CV
POCI
POCI
Q4 25
Q3 25
$-5.7M
Q2 25
$-9.6M
$-615.5K
Q1 25
$-2.0M
Q4 24
$-816.6K
Q3 24
$-343.0K
Q2 24
$-987.6K
Q1 24
$-322.7K
FCF Margin
CV
CV
POCI
POCI
Q4 25
Q3 25
-160.5%
Q2 25
-289.0%
-10.0%
Q1 25
-47.8%
Q4 24
-18.0%
Q3 24
-8.2%
Q2 24
-20.9%
Q1 24
-6.2%
Capex Intensity
CV
CV
POCI
POCI
Q4 25
Q3 25
0.3%
Q2 25
2.1%
0.7%
Q1 25
3.0%
Q4 24
0.7%
Q3 24
0.6%
Q2 24
0.2%
Q1 24
2.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CV
CV

Products$2.5M71%
Other$1.0M29%

POCI
POCI

Systems Manufacturing$5.2M70%
Other$1.1M15%
Ross Optical Industries$1.0M14%

Related Comparisons